Rhesus macaques and SIV infection.

CS Chie Sugimoto
KM Kristen M. Merino
AH Atsuhiko Hasegawa
XW Xiaolei Wang
XA Xavier A. Alvarez
HW Hiroshi Wakao
KM Kazuyasu Mori
WK Woong-Ki Kim
RV Ronald S. Veazey
ED Elizabeth S. Didier
MK Marcelo J. Kuroda
request Request a Protocol
ask Ask a question
Favorite

Thirty-nine infant rhesus macaques specific pathogen free for SIV, type D simian retrovirus, herpes B virus, and simian T-cell leukemia virus type 1 from the Tulane National Primate Research Center were used in this study (Table 1). Newborn macaques were removed from their mothers, reared in an animal biosafety level 2 (ABSL2) nursery, and studied in accordance with the standards of the Guide for the Care and Use of Laboratory Animals (62) and with approval by the Institutional Animal Care and Use Committee of Tulane University. Animals were inoculated intravenously with 100 50% tissue culture infective doses (TCID50) of SIVmac251 within 24 h of birth (n = 15) or between 53 and 105 days of age (n = 4). Humane euthanasia was conducted at the scheduled time points and/or when warranted by manifestations of clinical AIDS or morbidity as indicated in Table 1. Neonates were defined as less than 1 month of age, and infants were defined as less than 1 year old.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A